Afzal Hussain

InstitutionKing Saud University
AddressRiyadh
Saudi Arabia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in July 2020 and January 2021
    All Publications
    Bar chart showing 68 publications over 13 distinct years, with a maximum of 18 publications in 2019
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Asrani P, Hussain A, Nasreen K, AlAjmi MF, Amir S, Sohal SS, Hassan MI. Guidelines and Safety Considerations in the Laboratory Diagnosis of SARS-CoV-2 Infection: A Prerequisite Study for Health Professionals. Risk Manag Healthc Policy. 2021; 14:379-389. PMID: 33568956.
      Citations: 4     
    2. Jairajpuri DS, Hussain A, Nasreen K, Mohammad T, Anjum F, Tabish Rehman M, Mustafa Hasan G, Alajmi MF, Imtaiyaz Hassan M. Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations. Saudi J Biol Sci. 2021 Apr; 28(4):2423-2431. PMID: 33526965.
      Citations: 2     
    3. Rehman MT, AlAjmi MF, Hussain A. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19. Curr Pharm Des. 2021; 27(33):3577-3589. PMID: 33200697.
      Citations: 7     Fields:    Translation:HumansCells
    4. Hussain I, Hussain A, Alajmi MF, Rehman MT, Amir S. Impact of repurposed drugs on the symptomatic COVID-19 patients. J Infect Public Health. 2021 Jan; 14(1):24-38. PMID: 33341481.
      Citations: 2     Fields:    Translation:Humans
    5. Khan S, Fakhar Z, Hussain A, Ahmad A, Jairajpuri DS, Alajmi MF, Hassan MI. Structure-based identification of potential SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2020 Nov 19; 1-14. PMID: 33210561.
      Citations: 4     Fields:    
    6. AlAjmi MF, Azhar A, Owais M, Rashid S, Hasan S, Hussain A, Rehman MT. Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19. J Biomol Struct Dyn. 2021 10; 39(17):6676-6688. PMID: 32729392.
      Citations: 1     Fields:    Translation:Humans
    7. Mohammad T, Shamsi A, Anwar S, Umair M, Hussain A, Rehman MT, AlAjmi MF, Islam A, Hassan MI. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy. Virus Res. 2020 10 15; 288:198102. PMID: 32717346.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    8. Shamsi A, Mohammad T, Anwar S, AlAjmi MF, Hussain A, Rehman MT, Islam A, Hassan MI. Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy. Biosci Rep. 2020 06 26; 40(6). PMID: 32441299.
      Citations: 39     Fields:    Translation:Cells